| Role of radiation therapy in modulation of the tumor stroma and microenvironment H Menon, R Ramapriyan, TR Cushman, V Verma, HH Kim, ... Frontiers in immunology 10, 193, 2019 | 131 | 2019 |
| Role of miRNAs in immune responses and immunotherapy in cancer MA Cortez, S Anfossi, R Ramapriyan, H Menon, SC Atalar, M Aliru, ... Genes, Chromosomes and Cancer 58 (4), 244-253, 2019 | 128 | 2019 |
| Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis M Kose, N Senkal, T Tukek, T Cebeci, SC Atalar, M Altinkaynak, H Arici, ... European Review for Medical and Pharmacological Sciences 26, 7046-7052, 2022 | 7 | 2022 |
| RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES T Vassilakopoulos, B Ferhanoglu, N Horowitz, Z Mellios, L Kaynar, ... Hematological Oncology 39, 2021 | 3 | 2021 |
| Intravascular Large B-Cell Lymphoma Within the Appendix Presenting as Acute Abdomen: A Challenging Diagnosis for Hematologists SC Atalar, OM Akay, E Osmanbaşoğlu, H Masyan, OÇ Taşkın, ... Turkish Journal of Hematology 38 (1), 89, 2021 | 1 | 2021 |
| P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP T Vassilakopoulos, B Ferhanoglu, N Horowitz, J Apostolidis, Z Mellios, ... HemaSphere 7 (Suppl), 2023 | | 2023 |
| REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS T Vassilakopoulos, B Ferhanoglu, N Horowitz, Z Mellios, L Kaynar, ... Hematological Oncology 41, 410-411, 2023 | | 2023 |
| Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era TP Vassilakopoulos, F Panitsas, Z Mellios, J Apostolidis, A Piperidou, ... Blood 140 (Supplement 1), 9554-9556, 2022 | | 2022 |
| COVID-19 ve aşıları ile ilişkili rekürren perikardit olguları. A Yılmaz, O Çetin, G Alagöz, SC Atalar, S Amikishiyev, YG Solak, ... Journal of Turkish Society for Rheumatology 14, 2022 | | 2022 |
| CRISPRa-mediated induction of apoptosis in therapy-resistant glioblastoma cells via derepression of pro-apoptotic genes E Yilmaz, A Kayabolen, SC Atalar, B Yigit, B Ulukan, M Zeybel, ... Cancer Research 82 (12_Supplement), 6255-6255, 2022 | | 2022 |
| P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES T Vassilakopoulos, B Ferhanoglu, NA Horowitz, J Apostolidis, Z Mellios, ... HemaSphere 6, 1114-1115, 2022 | | 2022 |
